Anhydroparthenin as a dual-target inhibitor against Sterol C-24 methyltransferase and Sterol 14-α demethylase of Leishmania donovani: A comprehensive in vitro and in silico study-Reference-Cited by-同舟云学术

Anhydroparthenin as a dual-target inhibitor against Sterol C-24 methyltransferase and Sterol 14-α demethylase of Leishmania donovani: A comprehensive in vitro and in silico study

Published:2024-06 Issue: Volume:269 Page:132034
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Kumari Diksha,Kour Parampreet,Singh Chetan Paul,Choudhary Rinku,Ali Syed Mudassir,Bhayye Sagar,Bharitkar Yogesh P.,Singh Kuljit

Funder

Department of Science and Technology

Publisher

Elsevier BV

Reference80 articles.

1. A review of leishmaniasis: current knowledge and future directions;Mann;Curr. Trop. Med. Rep.,2021

2. Advancement in leishmaniasis diagnosis and therapeutics: an update;Kumari;Eur. J. Pharmacol.,2021

3. An insight into the current perspective and potential drug targets for visceral leishmaniasis (VL);Mansuri;Curr. Drug Targets,2020

4. Exploring the paradox of defense between host and Leishmania parasite;Kumari;Int. Immunopharmacol.,2022

5. Insights into the drug screening approaches in leishmaniasis;Gopu;Int. Immunopharmacol.,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing FDA approved drugs against Sterol C-24 methyltransferase of Leishmania donovani: A dual in silico and in vitro approach;Acta Tropica;2024-10

2. Exploring natural product library as potential target against sterol C-24 methyltransferase protein of Leishmania donovani;Natural Product Research;2024-08-19